Clinical Trials Feature Articles

  1. White Paper: The Application Of Novel Imaging Methods To New Drug Development 7/21/2008
    Considerable expertise is required to effectively design protocols that use mechanistic imaging in pharmaceutical trials. However, the potential rewards to sponsors of employing new imaging biomarkers are enormous if the appropriate expertise is applied. By Bruce J. Hillman, MD, Chief Scientific Officer, ACR Image Metrix
  2. Imaging In Clinical Trials: Frequently Asked Questions 7/21/2008
    Imaging can provide important endpoints to determine the effectiveness of experimental treatments. This is especially important in helping to determine whether to go forward from phases I and II to more advanced trials. By ACR Image Metrix
  3. Reducing Discharge By Monitoring Sieve Consumption 6/25/2008
    This client is a manufacturer of cake mixtures and bakery products sold primarily to the local bakers and “in-house” bakeries now found in most major supermarkets. Due to increased standards of quality, they wanted to install additional sieving and metal detection checks prior to final packaging. Submitted by ISL
  4. Leveraging Biomedical Engineering To Realize Life-Saving Combination Product Innovations 5/27/2008
    By Christine Ford, Event Director, PharmaMedDevice, Reed Life Sciences
    Biomedical engineering is responsible for some of today’s most important lifesaving innovations, ranging from imaging technologies to nanomedicine. Many innovations currently being developed using biomedical engineering are taking shape as combination products, which integrate a drug, a biologic and/or a medical device into a single product.
  5. White Paper: Leveraging Biomedical Engineering To Realize Life-Saving Combination Product Innovations 5/27/2008
    White Paper: Leveraging Biomedical Engineering To Realize Life-Saving Combination Product Innovations
  6. Cervical Cancer: Treatment Planning With PET/CT And USPIO MRI 5/21/2008
    Cervical cancer is the third most common gynecologic malignancy in the United States, causing 3,700 - 5,000 deaths annually. Cervical cancer is the only major gynecologic malignancy that is clinically staged. When compared to surgical staging, clinical staging is accurate in only 60% of cases. Submitted by ACR Image Metrix
  7. National Oncologic Pet Registry (NOPR) 5/21/2008
    The National Oncologic PET Registry (NOPR) arose in response to a Centers for Medicare and Medicaid Services (CMS) proposal to expand cancer-related coverage of positron emission tomography (PET) using f-18 fluoro deoxyglucose (FDG). Whereas FDG-PET was CMS-approved for only a limited number of cancers, CMS agreed to conditional coverage of most cancers and related indications for those patients enrolled in a clinical registry evaluating the impact of PET on cancer management. Submitted by ACR Image Metrix
  8. Breast Cancer: Screening With Digital Mammography (DMIST) 5/21/2008
    The main objective of the Digital Mammography Screening Trial (DMIST) was to compare the diagnostic performance of digital and conventional film mammography in a prospectively enrolled, screening cohort of asymptomatic women, across all digital mammography machine types. Submitted by ACR Image Metrix
  9. Amgen Finds Full System Integration The Right Prescription 4/24/2008
    Today, a completely integrated Andover Continuum system allows Amgen to control and monitor every aspect of their building, including card access, HVAC, freezer monitoring, CCTV, lighting, and process monitoring, from any of their workstations. Submitted by TAC
  10. Case Study: Amgen Finds Full System Integration The Right Prescription 4/24/2008
    Case Study: Amgen Finds Full System Integration The Right Prescription